Conflict of Interest statement
FW, YP, JB, MK, SB, JR, AS, JW, LL, JH declare no relevant conflict of interest. AEP has received research funding from AbbVie, Inc. SP receives support for the conduct of clinical trials through Boston Children’s Hospital from AlloVir, Atara, and Jasper, SP provides consulting (CellEvolve, Pierre Fabre) and receives honoraria from Regeneron, SP is an Inventor related to development of third party viral specific T cells program with all rights assigned to Memorial Sloan Kettering Cancer Center. JAP receives support for the conduct of clinical trials through Boston Children’s Hospital / Dana-Farber Cancer Institute from AbbVie, Ymab Therapeutics and Servier and is on the advisory board for foresee pharmaceuticals.